11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with ketamine in 1 studies
Studies (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Trials (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Recent Studies (post-2010) (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
---|---|---|---|---|---|
304 | 27 | 103 | 15,029 | 2,321 | 6,678 |
Protein | Taxonomy | 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (IC50) | ketamine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bafile, E; Compagnone, D; Curini, R; D'Ascenzo, G; Romolo, FS; Sergi, M | 1 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and ketamine
Article | Year |
---|---|
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Cocaine; Dronabinol; Humans; Illicit Drugs; Ketamine; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors | 2009 |